About: Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.86 (-3.35%)
PLRX NASDAQ Pliant Therapeutics Inc
Pliant Therapeutics Inc share price
Atividade de preço de PLRX
Último preço
$ 0,860
Variação (24h)
-0,03 USD (3,35%)
Volume
205.95K
Volume (média 4 sem.)
-
Abertura
$ 0,88
Variação do dia
$ 0,85 - $ 0,90
Fechamento anterior
$ 0,89
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
PLRX price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals